| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 02/19/2009 | US20090048203 Substituted adenines and the uses thereof |
| 02/19/2009 | US20090048195 Compositions and methods of sphingosine kinase inhibitors for use thereof in cancer therapy |
| 02/19/2009 | US20090048190 Antiviral activity and resolution of 2-hydroxymethyl-5(5-fluorocytosin-1-yl)-1,3-oxathiolane |
| 02/19/2009 | US20090048189 Tricyclic-nucleoside compounds for treating viral infections |
| 02/19/2009 | US20090048176 Antibacterial agent |
| 02/19/2009 | US20090048171 Treatment of viral infections |
| 02/19/2009 | US20090048165 Anti-hiv agent |
| 02/19/2009 | US20090048164 Therapeutic pro-apoptotic bh3-like molecules and methods for generating and/or selecting the same |
| 02/19/2009 | US20090048159 Kit for treating a health condition by inducing translocation of a calreticulin protein to a cellular membrane |
| 02/19/2009 | US20090048155 Methods for preventing and treating tissue injury and sepsis associated with Yersinia pestis infection |
| 02/19/2009 | US20090047741 Compositions and methods comprising a ligand of chemerin R |
| 02/19/2009 | US20090047363 Deodorant Antibacterial Fibrous Product |
| 02/19/2009 | US20090047353 Changing th1/th2 balance in split influenza vaccines with adjuvants |
| 02/19/2009 | US20090047342 Methods of Treating Infectious Diseases |
| 02/19/2009 | US20090047339 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof |
| 02/19/2009 | US20090047338 Method to Treat Flavivirus Infection with siRNA |
| 02/19/2009 | US20090047335 Anti-angiogenic peptides and methods of use thereof |
| 02/19/2009 | US20090047321 Antimicrobial compounds having protective or therapeutic leaving groups |
| 02/19/2009 | US20090047306 Adjuvant compositions |
| 02/19/2009 | US20090047303 Method for improving the immunogenicity of plasmodium antigens |
| 02/19/2009 | US20090047302 Chimaeric Human Papillomavirus 16 L1 Virus Like Particles and a Method for Preparing the Particles |
| 02/19/2009 | US20090047295 Methods and Compositions for Reducing Stemness in Oncogenesis |
| 02/19/2009 | US20090047286 H2n3 influenza a viruses and methods of use |
| 02/19/2009 | US20090047282 Prophylactic/Therapeutic Agent for Cancer |
| 02/19/2009 | US20090047280 Antibody inhibiting infection of papillomavirus |
| 02/19/2009 | US20090047269 Metabolomic cancer targets |
| 02/19/2009 | US20090047267 Process for the Preparation of A Non-Corrosive Base Solution And Methods Of Using Same |
| 02/19/2009 | US20090047262 Expression of class II transactivator fusion proteins for control of tumor growth |
| 02/19/2009 | US20090047253 Probiotic system for aquaculture |
| 02/19/2009 | US20090047252 Antiviral compounds |
| 02/19/2009 | US20090047249 Modulators of toll-like receptor 7 |
| 02/19/2009 | US20090047248 Triazolyl macrocyclic hepatitis c serine protease inhibitors |
| 02/19/2009 | US20090047247 Pyrrolidine Derivatives |
| 02/19/2009 | US20090047240 Chaperonin 10-induced immunomodulation |
| 02/19/2009 | US20090047239 Stabilised IL-21 Compositions |
| 02/19/2009 | US20090047238 Novel Spirotropane Compounds And Methods For The Modulation Of Chemokine Receptor Activity |
| 02/19/2009 | US20090047232 Formulation and method for treating animal waste |
| 02/19/2009 | US20090047217 Polynucleotides Encoding Members of the Human B Lymphocyte Activation Antigen B7 Family and Polypeptides Encoded Thereby |
| 02/19/2009 | US20090047211 Anti-mesothelin antibodies useful for immunological assays |
| 02/19/2009 | US20090047210 Cleavage of VEGF and VEGF receptor by wildtype and mutant MT-SP1 |
| 02/19/2009 | DE102007037579A1 Neue Benzimidazol-2-yl-alkylamine und ihre Anwendung als mikrobizide Wirkstoffe New benzimidazol-2-yl-alkylamines and their application as microbicidal agents |
| 02/19/2009 | DE102004014637B4 Nicht-metabolisierbares Aminosäureanalogon Non-metabolizable amino acid analogue |
| 02/19/2009 | CA2733706A1 Modulation of immune responses by administration of roxithromycin or its derivative |
| 02/19/2009 | CA2700923A1 Novel targets and compounds for therapeutic intervention of hiv infection |
| 02/19/2009 | CA2696478A1 Protein-polymer conjugates |
| 02/19/2009 | CA2695989A1 Certain nitrogen containing bicyclic chemical entities for treating viral infections |
| 02/19/2009 | CA2695475A1 Azabiphenylaminobenzoic acid derivatives as dhodh inhibitors |
| 02/19/2009 | CA2684873A1 Anti-bacterial drug targeting of genome maintenance interfaces |
| 02/18/2009 | EP2025754A2 Moraxella (Branhamella) catarrhalis antigens |
| 02/18/2009 | EP2025750A1 Novel targets and compounds for therapeutic intervention of HIV infection |
| 02/18/2009 | EP2025676A1 Novel indazole derivative having spiro ring structure in side chain |
| 02/18/2009 | EP2025666A2 Thiolalkyl benzoic acid derivatives |
| 02/18/2009 | EP2025337A1 External pharmaceutical composition |
| 02/18/2009 | EP2024393A2 Neutralizing antibodies to influenza viruses |
| 02/18/2009 | EP2024385A1 Betulin derived compounds useful as antibacterial agents |
| 02/18/2009 | EP2024376A1 Novel sulfonamidomethylphosphonate inhibitors of beta-lactamase |
| 02/18/2009 | EP2024375A1 Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors |
| 02/18/2009 | EP2024370A1 Spiro- (tho) benzopyran-2, 4' -piperidine-and cyclohexane derivatives as inhibitors of specific cell cycle enzymes |
| 02/18/2009 | EP2024355A2 Alkene piperidine derivatives as antiviral agents |
| 02/18/2009 | EP2023946A1 Inhibition of gliotoxin |
| 02/18/2009 | EP2023927A2 Deoxynojirimycin and d-arabinitol analogs and methods of using |
| 02/18/2009 | EP2023911A2 Compounds a-r-x for the manufacture of pharmaceutical preparations |
| 02/18/2009 | EP2023813A2 Magnetic microparticles comprising organic substances |
| 02/18/2009 | EP1877566B1 Enzymatic production of peracids using perhydrolytic enzymes |
| 02/18/2009 | EP1675852B1 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones |
| 02/18/2009 | EP1664052B1 Fused heterocycles as inhibitors of glutamate racemase (muri) |
| 02/18/2009 | EP1658068B1 Novel cycloalkyl[b] condensed indoles |
| 02/18/2009 | EP1629000B1 Macrocyclic isoquinoline peptide inhibitors of hepatitis c virus |
| 02/18/2009 | EP1533320B1 HUMAN IgM ANTIBODY INDUCING APOPTOSIS IN HIV-INFECTED CELLS AND REMEDY FOR HIV-INFECTION |
| 02/18/2009 | EP1458757B1 Process for the purification and/or isolation of biologically active granulocyte colony stimulating factor |
| 02/18/2009 | EP1140157B1 Streptococcus pneumoniae proteins and immunogenic fragments for vaccines |
| 02/18/2009 | EP1084137B1 Peptide inhibitors of hepatitis c virus ns3 protease |
| 02/18/2009 | EP1071955B2 Improved immunodiagnostic assays using reducing agents |
| 02/18/2009 | EP1028945B9 Substituted pyridine compounds as anti-inflammatory agents |
| 02/18/2009 | EP0941337B1 Synthesis and purification of hepatitis c virus-like particles |
| 02/18/2009 | CN101370830A Human monoclonal antibodies to CD70 |
| 02/18/2009 | CN101370818A RNAi inhibition of influenza virus replication |
| 02/18/2009 | CN101370802A Triazoloanilinopyrimidine derivatives for use as antiviral agents |
| 02/18/2009 | CN101370783A Salts of 1-alkylamino-1-desoxypolyols with 9-oxoacridine-10-acetic acid, medicinal preparations on their base, their use, preventive measures and treatment |
| 02/18/2009 | CN101370524A Lipopeptide compositions |
| 02/18/2009 | CN101370517A Peptide derived from hepatitis C virus |
| 02/18/2009 | CN101370514A Neisseria meningitidis vaccines and their use |
| 02/18/2009 | CN101370504A Long term treatment of HIV- infection with TCM278 |
| 02/18/2009 | CN101368167A Recombinant lactobacillus casei for co-expression of swine fever virus T cell epitope and pig parvoviral VP2 protein, and method of producing the same |
| 02/18/2009 | CN101367882A Sulfating numerator modification method of epimedium brevicornum polysaccharide |
| 02/18/2009 | CN101367879A Gastrodia elata polysaccharide, its sulfating derivant, preparation and application thereof |
| 02/18/2009 | CN101367872A Protein-polymer conjugates |
| 02/18/2009 | CN101367869A Polypeptide for preventing, diagnosing and treating hepatitis E virus, and vaccine as diagnosis agent of the same |
| 02/18/2009 | CN101367856A Methods and compositions for treating hepatitis c virus |
| 02/18/2009 | CN101367854A Macrolides with antibacterial activity |
| 02/18/2009 | CN101367853A 13-membered azalides and their use as antibiotic agents |
| 02/18/2009 | CN101367822A Novel dihydro arteannuin derivant, preparation method and uses as medicament |
| 02/18/2009 | CN101367818A Penem compound containing amine vinyl substituted sulfhydryl aza ring |
| 02/18/2009 | CN101367817A Carbpenem compound containing cyclohexenone formamido group |
| 02/18/2009 | CN101367816A Carbpenem derivants |
| 02/18/2009 | CN101367815A Six-membered ring methanamide substituted sulfhydryl pyrrolidine carbpenem compound |
| 02/18/2009 | CN101367814A Sulfhydryl pyrrolidine formyl piperidine substituted penem derivant |
| 02/18/2009 | CN101367813A Sulfhydryl pyrrolidine formyl arylamine heterocycle substituted penem derivant |
| 02/18/2009 | CN101367812A Sulfhydryl pyrrolidine formamido cyclopentene acid substituted penem derivant |
| 02/18/2009 | CN101367811A Carbon substituted penems antibiotics |